Artificial Intelligence in Decision Support Systems for Type 1 Diabetes

Abstract

Type 1 diabetes (T1D) is a chronic health condition resulting from pancreatic beta cell dysfunction and insulin depletion. While automated insulin delivery systems are now available, many people choose to manage insulin delivery manually through insulin pumps or through multiple daily injections. Frequent insulin titrations are needed to adequately manage glucose, however, provider adjustments are typically made every several months. Recent automated decision support systems incorporate artificial intelligence algorithms to deliver personalized recommendations regarding insulin doses and daily behaviors. This paper presents a comprehensive review of computational and artificial intelligence-based decision support systems to manage T1D. Articles were obtained from PubMed, IEEE Xplore, and ScienceDirect databases. No time period restrictions were imposed on the search. After removing off-topic articles and duplicates, 562 articles were left to review. Of those articles, we identified 61 articles for comprehensive review based on algorithm evaluation using real-world human data, in silico trials, or clinical studies. We grouped decision support systems into general categories of (1) those which recommend adjustments to insulin and (2) those which predict and help avoid hypoglycemia. We review the artificial intelligence methods used for each type of decision support system, and discuss the performance and potential applications of these systems.

The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations

“…For example, adherence to T2D medications to achieve euglycemia is demonstrably driven by cultural beliefs, values, social factors, religion, health literacy, and language barriers [ 95 , 96 ]. Similar issues are likely to follow in the T1D space, where AI algorithms are currently focused on automated insulin delivery systems but will likely shift toward the above dimensions in the near future [ 63 , 97 , 98 ].…”

Artificial Pancreas Control Strategies Used for Type 1 Diabetes Control and Treatment: A Comprehensive Analysis

“…Despite the significant developments, the specific model based on the personalization scheme that can adopt with the specific features of each patient is missing. In addition, the multi-criteria such as considering circadian variations, mixed meals, and the common problems of the disturbance rejections and sensor errors need significant developments [196]. Although both the MPC and PID approaches have shown promising results, confirming their validity with real experiments and clinical trials is required.…”

Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency

“…Many articles written by clinicians have used the words “dosing” 1 and “delivery” 2 to describe automated insulin systems. Many researchers have also described these systems as performing “dosing” 3 or “delivery” 4 of insulin, and on occasion as performing both of these terms 5 in the same article.…”